10x Genomics

Tetramer Shop is a developer of drug technology aims to MHC tetramers to make the testing and monitoring of antigen-specific T cells.

ReadCoor, Inc. is a technology company based in Cambridge, Massachusetts, specializing in the development and commercialization of a panomic spatial sequencing platform designed for researchers, clinicians, and pharmaceutical and diagnostics companies. The company's innovative platform, based on proprietary Fluorescent in situ Sequencing (FISSEQ) technology, enables the simultaneous detection and analysis of RNA, DNA, proteins, and therapeutics, while providing high-resolution three-dimensional imaging of tissue samples. This integration allows for comprehensive morphometric analysis and cellular localization, facilitating a deeper understanding of human biology and the advancement of therapeutic development. ReadCoor aims to support clients in accessing valuable clinical insights for treating various diseases, including cancer, infectious diseases, and neurological disorders. Established in 2016, ReadCoor operates as a subsidiary of 10x Genomics, Inc.

Cartana AB is a biotechnology company based in Solna, Sweden, specializing in mapping gene expression in brain tissue through In Situ Sequencing (ISS). Founded in 2017, Cartana's innovative technology allows for the simultaneous analysis of hundreds of genes within individual cells while preserving tissue morphology. This capability is essential for advancing research and biomarker discovery, treatment validation, and the development of future diagnostic tools. The company's flagship product, NeuroKit: Brain Cell Mapping, can identify over 100 genes in a single tissue section. Cartana also provides sequencing services that include sample preparation and analysis, facilitating deeper understanding of brain functions and diseases as well as tumors and other organs. As of August 2020, Cartana operates as a subsidiary of 10x Genomics, Inc.

Cartana AB is a biotechnology company based in Solna, Sweden, specializing in mapping gene expression in brain tissue through In Situ Sequencing (ISS). Founded in 2017, Cartana's innovative technology allows for the simultaneous analysis of hundreds of genes within individual cells while preserving tissue morphology. This capability is essential for advancing research and biomarker discovery, treatment validation, and the development of future diagnostic tools. The company's flagship product, NeuroKit: Brain Cell Mapping, can identify over 100 genes in a single tissue section. Cartana also provides sequencing services that include sample preparation and analysis, facilitating deeper understanding of brain functions and diseases as well as tumors and other organs. As of August 2020, Cartana operates as a subsidiary of 10x Genomics, Inc.

Spatial Transcriptomics offers a technology that allows to perform RNA sequencing in 2D.

Epinomics is revolutionizing personalized medicine through scientific research, deep analytics, and clinical application development.